Here are some COVID-19 headlines:
● Philadelphia is expected to announce an indoor mask mandate for all businesses, or allow businessess to go mask free if they require proof of vaccination for employees and patrons.
● The Washington Post examines how the world is living and dying with COVID-19.
● COVID has given us a greater glimpse of what working from both home and the office looks like. But is ‘hybrid work’ the best way to work?
● Looking at what’s true and false about the COVID vaccine, fertility and miscarriage claims.
● A Pennsylvania vaccine expert tells CNN that the data does not yet show a need for COVID-19 boosters.
● As the variant expands and gains a greater foothold, more children are falling ill because more are being infected, according to The Atlantic.
_____________

_____________
Pittsburgh Public Schools
to delay start of school year
by two weeks due to busing issues
Pittsburgh Public Schools officials said Tuesday they have taken multiple steps in an effort to eliminate the district’s transportation shortage before the start of the fall semester — including a plan to push back the first day for students by about two weeks.
District officials said the school system remains short about 6,000 bus seats for students for the 2021-22 school year.
The district said it plans to add several transportation companies that would provide about 100 new bus drivers to the city schools. To give those bus companies time to onboard new drivers, district administrators said they want to push back the first day of school for students from Aug. 25 to Sept. 8.
“These are some difficult decisions we are going through right now based on our current state and the current context we’re in right now,” Superintendent Anthony Hamlet said Tuesday morning during a virtual news conference. “It’s not ideal times. We’re trying to make sure that we get as many students into school as we can.”
— Post-Gazette
_____________
UPMC doctors discuss
the evolution of COVID-19
antibody treatment
As the new COVID-19 variants continue to spread throughout Pittsburgh, UPMC leaders on Tuesday said they see success with antibody treatment and are expanding its use to people at a high risk of developing the disease. The doctors highlighted the monoclonal antibody infusion treatments offered at their facilities for eligible patients.
“These antibodies are constantly studied and changed in order to be effective against all of the variants. We actually find them and make them from patients who have recovered from COVID-19, and we screen natural immunity to see which antibodies the human body produces that are most effective at what we call neutralizing the virus,” said Dr. Erin McCreary, UPMC infectious diseases pharmacist and clinical assistant professor in the University of Pittsburgh Division of Infectious Diseases.
In 2020, the Food and Drug Administration issued an emergency use authorization to permit the monoclonal antibodies as a treatment option for COVID-19 patients. Used like a medicine, these antibodies decrease the likelihood of hospitalizations and death for those diagnosed with COVID-19.
— Post-Gazette
_____________
A dangerous time
for children in the U.S.
Students will be contending with one of the most dangerous times in the pandemic for children, CNN is reporting, citing and expert that says officials will have to consider many measures to keep them safe from COVID-19.
"We have the more contagious Delta variant, we have surges and we have so many adults letting down their guard, not wearing masks, not getting vaccinated," Dr. Leana Wen told CNN's Wolf Blitzer on Tuesday. "That's contributing to this really dangerous environment for children."
_____________
WHO will testing 3 drugs for use against coronavirus
The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus.
In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were chosen by an independent panel based on the likelihood they could prevent deaths in people hospitalized for coronavirus.
They include artesunate, a malaria drug, the cancer drug imatinib, and infliximab, currently used in people with diseases of the immune system.
WHO’s ongoing study into COVID-19 treatments previously assessed four drugs. Among its findings, the agency determined that remdesivir and hydroxychloroquine didn’t help people hospitalized with the virus. WHO’s research includes thousands of researchers in hundreds of hospitals in 52 countries.
“Finding more effective and accessible therapeutics for COVID-19 patients remains a critical need,” says WHO director-general Tedros Adhanom Ghebreyesus.
— Associated Press
_____________
A scientist who came out
of retirement to help fight
COVID loses his own battle
Thomas Hodge III logged on from his hospital bed for what would be his last weekly Zoom meeting with some 200 scientific collaborators. Gaunt and unshaven, he conferred with the group on how to defeat this country’s latest surge of COVID-19 — the virus Hodge’s body was battling a second time.
The prominent immunologist died two days later of complications from the disease. One state away, mere hours later, a beloved granddaughter succumbed to kidney cancer.
He was 69. She was 6.
“Dad hadn’t been well, but he didn’t want anyone focusing on him,” said Leslie Turner, one of Hodge’s daughters and one of Izabella Bondell’s aunts. “His spirit broke when he couldn’t fix Izzy.”
Hodge, former director of immunogenetics at the Centers for Disease Control and Prevention, spent decades fighting diseases such as AIDS and Ebola. He opted out of retirement in early 2020 to focus on the latest global public health threat and co-founded the CrisiScience Collaborative, a who’s who of research and medicine that has since met virtually almost every week to share insights and developments on the pandemic.
He was an ardent proponent of the country’s mass vaccination effort, yet he cautioned against relying too heavily on the vaccines. He also warned against abandoning precautions such as masking and social distancing.
“He wanted people to wake up, to observe how serious this pandemic is,” recounted his CrisiScience co-founder, Steve Winston, former chief scientist of the Idaho National Laboratory.
At his home on St. Simons Island, Ga., Hodge beat the virus last year. He hoped that bout would stave off a future infection, especially because a medical condition meant he could not get vaccinated.
— The Washington Post






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.